A Study of Monthly Risedronate for Osteoporosis

NCT00247273 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1294

Enrollment

INDUSTRY

Sponsor class

Conditions

Postmenopausal Osteoporosis

Interventions

DRUG: risedronate
DRUG: risedronate

Sponsor

Warner Chilcott

Collaborators

[object Object]